Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 21 and up

Mapping smoking environments with smartphone photos and AI to help people quit

Official title: Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment

Run by Duke University · NCT07089901 · Data updated 2026-11-12

This project will see if smartphone photos, sensors, and AI can identify places and situations that trigger smoking for daily smokers who plan to quit and are using nicotine patches.

More Smoking trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages21 Years and up
SexAll
Enrollment600 (estimated)
SponsorDuke University
Academic / other
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedMay 6, 2026
Main results expectedMarch 31, 2030
Study endsMarch 31, 2030
Registry record updatedJuly 23, 2026
Trial IDNCT07089901 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 21 or older who smoke at least 10 cigarettes per day, have smoked daily for two or more years, plan to set a quit date within a month, and own an iPhone or Android phone that can run the study apps.

Probably not a fit

People who are pregnant or breastfeeding, already using cessation treatments or regular non-cigarette nicotine products, have unstable medical conditions, or lack a compatible smartphone are unlikely to benefit from this specific protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults who smoke daily and plan to quit will use study smartphone apps to take photos and collect sensor data around real-world moments of smoking and craving. Computer vision and other AI tools will analyze those images and data to identify environmental features linked to smoking behavior. Participants will also receive transdermal nicotine replacement therapy and follow a target quit date while researchers link environmental markers to craving and relapse risk. The goal is to create objective environmental signatures that could guide personalized relapse-prevention strategies.

Why it matters

Potential benefit: If successful, this could help identify high-risk places and triggers so clinicians and smokers can tailor reminders or support to reduce relapse and improve quit success alongside nicotine patches.

How similar studies have gone: Prior studies using sensors and ecological momentary assessment have shown promise linking environment to smoking, but full computer-vision-based digital envirotyping to guide cessation is novel with limited direct evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. 21 years of age or older;
2. Smoke ≥ 10 cigarettes/day
3. Smoking daily for ≥ 2 years, with a stable smoking pattern for the past 6 months;
4. Intention to quit smoking and set a target quit date in the next 1 month;
5. Have an iPhone or Android smartphone capable of running the photoEMA and iCO software
6. Positive Urine Cotinine Test

Exclusion Criteria:

1. Pregnant, breastfeeding, or planning to become pregnant during the course of the study;
2. Currently in smoking cessation treatment or current use of smoking cessation products;
3. Regular use (i.e. \>9 days/month) of non-cigarette nicotine-containing products (e.g. cigarillos, e-cigarettes);
4. Anticipating major life changes (e.g. new job, birth of a child) during the course of the study;
5. Unstable medical conditions;
6. Contraindication for nicotine replacement therapy.

Where it's running

  • Duke University Medical Center
    Durham, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Francis J. McClernon, PhD — Duke University
  • Study coordinator: Laura Van Althuis, MHA
  • Email: deduce@duke.edu
  • Phone: 919-668-4312

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.